Details for 2016738155

Up to date per 04.04.2026

Actions

Title / Product Name

KRYSTALLINE FORM DES N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINS ZUR BEHANDLUNG VON INFEKTIONEN DURCH DAS RESPIRATORISCHE SYNZYTIALVIRUS (RSV)

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016738155

EP Publication Number

3322704

E-Number

1206552

Language

PCT Number

EP16066482

Publication Date

23.05.2018 A

27.11.2019 B1

Registration Date

27.11.2019

AT Publication Date

15.12.2019

Application Date

12.07.2016

Registration Number

Priorities

16.07.2015

PCT/CN2015/084225

IPC

C07D 417/04 20060101AFI20190531BHEP

Maximum Duration of Protection

12.07.2036

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

No representatives present

Inventor

ZHANG, WeiBuilding No. 5 Lane 720 Cailun Road Shanghai 201203CN

WANG, LinBuilding No. 5 Lane 720 Cailun Road Shanghai 201203CN

LI, WeiRoom 1301 Building No. 11 No.688 Yierba Jinian Shanghai 200435CN